5. Li Z, Jiang W, Zhou H, et al. Comparison of zuberitamab plus CHOP versus rituximab plus CHOP for the treatment of drug-naïve patients diagnosed with CD20-positive diffuse large B-cell lymphoma: a phase 3 tri...
6.Curran K, Thamm DH.Retrospective analysis for treatment of naïve canine multicentric lymphoma with a 15-week, maintenance-free CHOP protocol. 7.Vet Comp Oncol. 2016;14(Suppl 1):147-155. doi:10.1111/vco.12163 8.Thamm DH, Vail DM, Post GS, et al.Alternating rabacfosadine/doxorubicin:...
The article reports on treatment of plasmablastic lymphoma (PBL) with human immunodeficiency virus (HIV) infection with use of inhibitor bortezomib plus CHOP (cyclophosphamide, doxorubicine, vincristine and prednisone). It states that lesion biopsy showed presence of plasmablastic cells with prominent ...
2024年7月29日，上海交通大学医学院附属瑞金医院赵维莅团队在期刊《Lancet Western Pacific》上发表了题为“Targeted agents plus CHOP compared with CHOP as the first-line treatment for newly diagnosed patients with peripheral T-cell lymphoma (GUIDANCE-03): an open-label, multicentre phase 2 clinical tri...
Maria E Nizzoli,et al. Impact of immunochemotherapy with R-bendamustine or R-CHOP for treatment naïve advanced-stage follicular lymphoma: A subset analysis of the FOLL12 trial by Fondazione Italiana Linfomi.Hematol Oncol . 2023 M...
2024年7月29日,上海交通大学医学院附属瑞金医院赵维莅团队在期刊《Lancet Western Pacific》上发表了题为“Targeted agents plus CHOP compared with CHOP as the first-line treatment for newly diagnosed patients with peripheral T-cell lymphoma (GUIDANCE-03): an open-label, multicentre phase 2 clinical tria...
[19] Yhim HY, Yoon DH, Kim SJ, et al. First-line treatment for primary breast diffuse large B-cell lymphoma using immunochemotherapy and central nervous system prophylaxis:A multicenter phase 2 trial[J]. Cancers (Basel), 2020, 12(8):2192. ...
There were no protocol treatment-related deaths, nor were there any fatal infections attributable to subsequent lymphoma treatment. At 15 years, the cumulative incidence of non-haematological and haematological malignancies was 12.8% and 3.7% respectively. Histological transformation appeared after a median...
[4] Hornberger JC, Best JH. Cost utility in the United States of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone for the treatment of elderly patients with diffuse large B-cell lymphoma[J]. Cancer, 2005,103(8):1644-1651. ...
2024年7月29日,上海交通大学医学院附属瑞金医院赵维莅团队在期刊《Lancet Western Pacific》上发表了题为“Targeted agents plus CHOP compared with CHOP as the first-line treatment for newly diagnosed patients with peripheral T-cell lymphoma (GUIDANCE-03): an open-label, multicentre phase 2 clinical tria...